Abiopharma

NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026

Plus Therapeutics Highlights Three REYOBIQ™ Clinical Data Presentations at 2025 WFNOS/SNO Annual Meeting

NeuroSense to Hold Pre-NDS Meeting with Health Canada in April 2026

Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer

Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors

Tilray Releases the Ultimate 2025 Holiday Drink Gift Guide, Celebrating Seasonal Sips and Moments of Connection from Coast to Coast

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement

Canopy Growth Communication - Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment

uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease

Insulet - Insulet Announces FDA 510(k) Clearance ofOmnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience